Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 18.27 is in line with its 5-year average of 19.16, near the low end of its 5-year range (12.36–40.14).
As of the fiscal period ended Tuesday, June 30, 2026. 11.38% below its 12-month average of 20.61.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 18.27.
QUICK RATIO (ACID-TEST)
18.27
QUICK RATIO (ACID-TEST) AVG TTM
20.61
QUICK RATIO (ACID-TEST) AVG 3Y
19.07
QUICK RATIO (ACID-TEST) AVG 5Y
19.16
QUICK RATIO (ACID-TEST) AVG 10Y
N/A
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
-11.38%
CURRENT VS 3Y AVG
-4.22%
CURRENT VS 5Y AVG
-4.64%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.35
median of 871 covered companies
CURRENT VS SECTOR MEDIAN
+445.31%
vs the sector median at left
Relay Therapeutics, Inc.
Market Cap
$4.02B
Quick Ratio (Acid-Test)
18.27
TTM Avg
20.61
3Y Avg
19.07
5Y Avg
19.16
Market Cap
$4.05B
Quick Ratio (Acid-Test)
12.63
TTM Avg
10.52
3Y Avg
9.25
5Y Avg
8.76
Market Cap
$3.97B
Quick Ratio (Acid-Test)
1.21
TTM Avg
1.33
3Y Avg
1.21
5Y Avg
1.93
Market Cap
$3.82B
Quick Ratio (Acid-Test)
1.42
TTM Avg
24.66
3Y Avg
24.27
5Y Avg
16.20
Market Cap
$4.29B
Quick Ratio (Acid-Test)
16.24
TTM Avg
19.89
3Y Avg
20.20
5Y Avg
22.94
Market Cap
$4.40B
Quick Ratio (Acid-Test)
4.68
TTM Avg
3.02
3Y Avg
3.88
5Y Avg
4.28
Market Cap
$4.43B
Quick Ratio (Acid-Test)
0.66
TTM Avg
0.63
3Y Avg
0.81
5Y Avg
1.13
Market Cap
$4.44B
Quick Ratio (Acid-Test)
5.08
TTM Avg
3.83
3Y Avg
4.06
5Y Avg
4.06
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Relay Therapeutics, Inc. (RLAY) | $4.02B | 18.27 | 20.61 | 19.07 | 19.16 |
| AbCellera Biologics Inc. (ABCL)vs › | $4.05B | 12.63 | 10.52 | 9.25 | 8.76 |
| ICU Medical, Inc. (ICUI)vs › | $3.97B | 1.21 | 1.33 | 1.21 | 1.93 |
| LivaNova PLC (LIVN)vs › | $4.14B | 1.21 | 1.83 | 2.18 | 1.91 |
| Regencell Bioscience Holdings Limited (RGC)vs › | $3.82B | 1.42 | 24.66 | 24.27 | 16.20 |
| Edgewise Therapeutics, Inc. (EWTX)vs › | $4.29B | 16.24 | 19.89 | 20.20 | 22.94 |
| Adaptive Biotechnologies Corporation (ADPT)vs › | $4.40B | 4.68 | 3.02 | 3.88 | 4.28 |
| Indivior Pharmaceuticals Inc (INDV)vs › | $4.43B | 0.66 | 0.63 | 0.81 | 1.13 |
| Heartflow, Inc. Common Stock (HTFL)vs › | $4.44B | 5.08 | 3.83 | 4.06 | 4.06 |
| Veracyte, Inc. (VCYT)vs › | $3.57B | 8.80 | 6.13 | 5.10 | 7.69 |
Quick Ratio
18.27
Excludes inventory
Current Ratio
18.27
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 18.27 |
| 2026-03-31 | 22.13 |
| 2025-12-31 | 22.61 |
| 2025-09-30 | 19.14 |
| 2025-06-30 | 20.92 |
| 2025-03-31 | 19.96 |
| 2024-12-31 | 15.95 |
| 2024-09-30 | 18.42 |
| 2024-06-30 | 15.64 |
| 2024-03-31 | 20.73 |
| 2023-12-31 | 25.44 |
| 2023-09-30 | 16.39 |
| 2023-06-30 | 12.36 |
| 2023-03-31 | 13.44 |
| 2022-12-31 | 15.81 |
| 2022-09-30 | 15.22 |
| 2022-06-30 | 19.49 |
| 2022-03-31 | 21.97 |
| 2021-12-31 | 40.14 |
| 2021-09-30 | 22.42 |
| 2021-06-30 | 26.84 |
| 2021-03-31 | 46.16 |
| 2020-12-31 | 56.49 |
| 2020-09-30 | 46.08 |
| 2020-06-30 | 24.74 |
| 2020-03-31 | 29.34 |
| 2019-12-31 | 30.08 |
| 2019-09-30 | 0.00 |
| 2019-06-30 | 0.00 |
| 2019-03-31 | 0.00 |
